Corient Private Wealth LP purchased a new stake in shares of CorVel Corp. (NASDAQ:CRVL – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,913 shares of the business services provider’s stock, valued at approximately $3,183,000.
Other hedge funds have also recently made changes to their positions in the company. Royal Bank of Canada grew its position in shares of CorVel by 12.5% during the first quarter. Royal Bank of Canada now owns 51,261 shares of the business services provider’s stock worth $5,739,000 after purchasing an additional 5,703 shares in the last quarter. AQR Capital Management LLC raised its stake in CorVel by 4.0% during the 1st quarter. AQR Capital Management LLC now owns 26,468 shares of the business services provider’s stock valued at $2,964,000 after purchasing an additional 1,013 shares during the period. Integrated Wealth Concepts LLC lifted its holdings in CorVel by 11.4% in the 1st quarter. Integrated Wealth Concepts LLC now owns 3,800 shares of the business services provider’s stock worth $425,000 after purchasing an additional 389 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in CorVel by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,846 shares of the business services provider’s stock worth $1,774,000 after purchasing an additional 702 shares in the last quarter. Finally, Millennium Management LLC lifted its holdings in CorVel by 127.4% in the 1st quarter. Millennium Management LLC now owns 48,182 shares of the business services provider’s stock worth $5,395,000 after purchasing an additional 26,990 shares in the last quarter. Institutional investors own 51.36% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on CRVL. Weiss Ratings upgraded shares of CorVel from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, July 16th. Wall Street Zen upgraded shares of CorVel from a “hold” rating to a “buy” rating in a research report on Saturday, May 30th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company presently has an average rating of “Hold”.
Insiders Place Their Bets
In related news, Director Jeffrey J. Michael sold 9,000 shares of the business’s stock in a transaction on Tuesday, June 9th. The stock was sold at an average price of $60.98, for a total transaction of $548,820.00. Following the completion of the transaction, the director owned 559,721 shares in the company, valued at $34,131,786.58. The trade was a 1.58% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Jennifer Yoss sold 2,100 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $70.92, for a total transaction of $148,932.00. Following the sale, the vice president directly owned 2,173 shares of the company’s stock, valued at $154,109.16. This represents a 49.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 16,174 shares of company stock worth $1,033,676 over the last three months. 39.72% of the stock is currently owned by corporate insiders.
CorVel Stock Performance
CRVL stock opened at $69.74 on Wednesday. The firm has a fifty day moving average price of $63.84 and a 200 day moving average price of $58.63. CorVel Corp. has a fifty-two week low of $44.83 and a fifty-two week high of $93.45. The firm has a market cap of $3.56 billion, a PE ratio of 31.00 and a beta of 0.97.
CorVel (NASDAQ:CRVL – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The business services provider reported $0.63 EPS for the quarter. The firm had revenue of $259.93 million during the quarter. CorVel had a net margin of 11.72% and a return on equity of 29.92%.
About CorVel
CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.
The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).
Further Reading
- Five stocks we like better than CorVel
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding CRVL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CorVel Corp. (NASDAQ:CRVL – Free Report).
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.
